The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation
Open accessAbstract
In cortical regions of brains from individuals with preclinical or clinical Alzheimer's disease (AD), extracellular β-amyloid (Aβ) deposition precedes the aggregation of pathological intracellular tau (the product of the gene microtubule-associated protein tau (MAPT)). To our knowledge, current mouse models of tauopathy reconstitute tau pathology by overexpressing mutant human tau protein. Here, through a homologous recombination approach that replaced the entire murine Mapt gene with the human ortholog, we developed knock-in mice with humanized Mapt to create an in vivo platform for studying human tauopathy. Of note, the humanized Mapt expressed all six tau isoforms present in humans. We next cross-bred the MAPT knock-in mice with single amyloid precursor protein (App) knock-in mice to investigate the Aβ–tau axis in AD etiology. The double-knock-in mice exhibited higher tau phosphorylation than did single MAPT knock-in mice but initially lacked apparent tauopathy and neurodegeneration, as observed in the single App knock-in mice. We further observed that tau humanization significantly accelerates cell-to-cell propagation of AD brain-derived pathological tau both in the absence and presence of Aβ-amyloidosis. In the presence of Aβ-amyloidosis, tau accumulation was intensified and closely associated with dystrophic neurites, consistently showing that Aβ-amyloidosis affects tau pathology. Our results also indicated that the pathological human tau interacts better with human tau than with murine tau, suggesting species-specific differences between these orthologous pathogenic proteins. We propose that the MAPT knock-in mice will make it feasible to investigate the behaviors and characteristics of human tau in an animal model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“However, APPNL‐G‐F/MAPT do not develop neurofibrillary tangles and neuronal loss until 24 months, 73 and remain transcriptomically undercharacterized.”
From Unique transcriptomic alterations in 5XFAD;PS19 mouse model identify glial lipid dysregulation and coordinated microglial–oligodendrocyte responses (2026) · cites this paper as [73]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More physiological double knock‐in models express humanized mutant APP and MAPT under endogenous promoters. 73 , 74”
From Unique transcriptomic alterations in 5XFAD;PS19 mouse model identify glial lipid dysregulation and coordinated microglial–oligodendrocyte responses (2026) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human MAPT KI models exhibit delayed tau pathology, as does a cross between the two KI models (Saito et al., 2019; Islam et al., 2023).”
From β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer’s disease (2024) · cites this paper as Saito et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our results show that this model provides an appealing alternative to the double APPNL-G-F × MAPT KI model, which develop both MAPT pathologies very slowly (Saito et al., 2019).”
From β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer’s disease (2024) · cites this paper as Saito et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since expressing physiological levels of tau transgene has been shown to be overall benign and only produces pathology very late in life (37, 38), our reasoning could be justified as this was a comparative neuropathologic study of three different variants of tau, all of which had equivalent expression levels.”
From Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation (2022) · cites this paper as [38]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As shown by other groups (37, 38), WT tau is not generally amenable to form NFT.”
From Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation (2022) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The hTau-KI human MAPT knock-in mouse model lacks apparent tau pathology, but has been shown to enhance tau propagation with exposure to AD-derived tau aggregates (Hashimoto, Matsuba et al. 2019, Saito, Mihira et al. 2019).”
From SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain (2026) · cites this paper as Saito, Mihira et al. 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Self-citationBuée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142
Single App knock-in mouse models of Alzheimer’s disease
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., & Saido, T. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3697 · Cited by 1,366
Self-citationTau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.
Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B., Geschwind, D., Bird, T., McKeel, D., Goate, A., et al. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,024
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 248
Emmerson, J. T., Carmo, S. D., Liu, Y., Shalhoub, A., Ai, L., Bonomo, Q., Malcolm, J. C., Breuillaud, L., & Cuello, A. C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106227 · Cited by 11
Benskey, M. J., Panoushek, S., Saito, T., Saido, T. C., Grabinski, T. M., & Kanaan, N. M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1265151 · Cited by 13
Self-citationHirota, Y., Sakakibara, Y., Takei, K., Nishijima, R., Sekiya, M., & Iijima, K. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230121 · Cited by 10
Portal, B., Södergren, M., Borrell, T. P. I., Giraud, R., Metzendorf, N. G., Hultqvist, G., Nilsson, P., & Lindskog, M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231461 · Cited by 10
Mishra, R., & Upadhyay, A. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05668-y · Cited by 11
Morrone, C. D., Tsang, A. A., & Yu, W. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00877-2 · Cited by 11
de Fisenne, M.-A., Yilmaz, Z., Decker, R. D., Suain, V., Buée, L., Ando, K., Brion, J., & Leroy, K. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105875 · Cited by 10
Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11
Ganesan, K., Rentsch, P., Langdon, A., Milham, L. T., & Vissel, B. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1357405 · Cited by 11
Dysregulation of neuroproteasomes by ApoE isoforms drives endogenous Tau aggregationPreprint
Paradise, V., Sabu, M., Bafia, J., Sharif, N., Nguyen, C., Konrad-Vicario, K., Mukim, R. D., Wang, X., Corjuc, B., Fu, J. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.29.518293 · Cited by 10
MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons
Xu, H. W., Qiu, Q., Hu, P., Hoxha, K., Jang, E., O’Reilly, M., Kim, C., He, Z., Marotta, N. P., Changolkar, L. N., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02703-3 · Cited by 10
Self-citationAn Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease
Lopes, P. A., Pádua, M. S., & Guil‐Guerrero, J. L. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2010002 · Cited by 9
Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research
Szegvari, E., Holec, S. A. M., & Woerman, A. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70021 · Cited by 8
Cardona, C. L., Wei, L., Kim, J., Angeles, E., Singh, G., Chen, S., Patel, R., Ifediora, N., Canoll, P., Teich, A. F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03562-9 · Cited by 8
Can accelerated ageing models inform us on age‐related tauopathies?
Han, Z. Z., Fleet, A., & Larrieu, D. (2023) · Aging Cell · doi:10.1111/acel.13830 · Cited by 10
Hamilton, J., Xu, K., Geremia, N. M., Prado, V. F., Prado, M. A. M., Brown, A. M., & Baron, C. A. (2023) · Imaging Neuroscience · doi:10.1162/imag_a_00055 · Cited by 8
Hashim, K. N. B., Matsuba, Y., Takahashi, M., Kamano, N., Tooyama, I., Saido, T. C., & Hashimoto, S. (2024) · FEBS Letters · doi:10.1002/1873-3468.14895 · Cited by 9
Self-citationBoscher, E., Hernandez-Rapp, J., Petry, S., Keraudren, R., Rainone, S., Loiselle, A., Goupil, C., Turgeon, A., St‐Amour, I., Planel, E., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.578720 · Cited by 8
Finneran, D. J., Desjarlais, T., Henry, A., Jackman, B. M., Gordon, M. N., & Morgan, D. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12470 · Cited by 7
Iwata, N., Tsubuki, S., Sekiguchi, M., Watanabe-Iwata, K., Matsuba, Y., Kamano, N., Fujioka, R., Takamura, R., Watamura, N., Kakiya, N., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402650 · Cited by 8
Self-citationAnimal models of tau propagation in Alzheimer's disease
Masuda‐Suzukake, M., Shimonaka, S., Nonaka, T., & Hasegawa, M. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104960 · Cited by 7
Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau
Mestdagh, C. F. D. V., Witte, M. E., Scheper, W., Smit, A. B., Henning, R. H., & van Kesteren, R. E. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01800-4 · Cited by 7
Severe neurodegeneration in brains of transgenic rats producing human tau prions
Ayers, J. I., Lopez, T. P., Steele, I. T., Oehler, A., Roman-Albarran, R., Cleveland, E., Chong, A., Carlson, G. A., Condello, C., & Prusiner, S. B. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02771-5 · Cited by 7
Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
Lim, D., Matute, C., Cavaliere, F., & Verkhratsky, A. (2025) · Handbook of Clinical Neurology · doi:10.1016/b978-0-443-19102-2.00012-0 · Cited by 8
Tauopathies: The Role of Tau in Cellular Crosstalk and Synaptic Dysfunctions
Caamaño-Moreno, M., & Gargini, R. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.02.034 · Cited by 7
Emerging concepts towards a translational framework in Alzheimer’s disease
Cozachenco, D., Zimmer, E. R., & Lourenco, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105246 · Cited by 7
Mizuno‐Iijima, S., Nakashiba, T., Ayabe, S., Nakata, H., Ike, F., Hiraiwa, N., Mochida, K., Ogura, A., Masuya, H., Kawamoto, S., et al. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09916-x · Cited by 7
Atwa, A., Alhadidy, M. M., Lamp, J. A., Combs, B., & Kanaan, N. M. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00473 · Cited by 6
Hromádková, L., Kim, C., Haldiman, T., Peng, L., Zhu, X., Cohen, M. L., de Silva, R., & Safar, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01133-0 · Cited by 6
de Gérando, A. M., Khasnavis, A., Welikovitch, L. A., Bhavsar, H., Glynn, C. A., Quittot, N., Perbet, R., & Hyman, B. T. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01849-1 · Cited by 6
Synaptic alterations associated with disrupted sensory encoding in a mouse model of tauopathy
Meftah, S., Cavallini, A., Murray, T. K., Jankowski, Ł., Bose, S., Ashby, M. C., Brown, J. T., & Witton, J. (2024) · Brain Communications · doi:10.1093/braincomms/fcae134 · Cited by 6
Jiang, L., Roberts, R., Wong, M., Zhang, L., Webber, C. J., Kilci, A., Jenkins, M., Sun, G., Rashad, S., Sun, J., et al. (2023) · Research Square · doi:10.1101/2023.03.28.534515 · Cited by 5
Self-citationSong, S., Liu, Q., Chen, R., Chen, P., Tao, M., Li, S., Guo, L., Zhu, X., Liu, Y., Liu, L., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02032-w · Cited by 5
Self-citationExperimental modeling for tauopathies: An isogenic panel of humanized MAPT knock-in mice
Morito, T., & Watamura, N. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104986 · Cited by 5
Experimental models of prion‐like protein propagation
Hasegawa, M. (2020) · Neuropathology · doi:10.1111/neup.12656 · Cited by 5
In Vivo Seeding of Amyloid-β Protein and Implications in Modeling Alzheimer’s Disease Pathology
Liu, Q., Song, S., Liu, L., & Hong, W. (2025) · Biomolecules · doi:10.3390/biom15040571 · Cited by 5
Spencer, B. J., Schueler, A., Sung, D., & Rissman, R. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106942 · Cited by 4
Advancing Alzheimer’s research by improving disease modeling of secondary tauopathy
Roy, E. R., & Cao, W. (2025) · npj Dementia · doi:10.1038/s44400-025-00044-w · Cited by 4
Paradise, V., Konrad, K. D., Nguyen, C., Sharif, N. A., Wang, X., Mukim, R. D., Sabu, M., Corjuc, B. T., Bafia, J., Fu, J. M., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02297-x · Cited by 4
Is Gulf War Illness a prolonged early phase tauopathy?
Baas, P. W., Sullivan, K. A., Terry, A. V., Case, K., Yates, P. L., Sun, X., Raghupathi, R., Huber, B. R., & Qiang, L. (2023) · Cytoskeleton · doi:10.1002/cm.21786 · Cited by 4
Multifactorial glial responses and their contributions to Alzheimer's disease continuum
Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4
Self-citationBansal, V. A., Tan, J. M., Soon, H. R., Zainolabidin, N., Saido, T. C., & Ch’ng, T. H. (2024) · eLife · doi:10.7554/elife.92069.3 · Cited by 4
Self-citationPrion-like transmission of human tau strains in the mouse brain
Lövestam, S., Shimozawa, A., Tarutani, A., Ohtani, R., Masuda‐Suzukake, M., Hasegawa, K., Robinson, A., Saito, Y., Murayama, S., Yoshida, M., et al. (2026) · Nature · doi:10.1038/s41586-026-11061-x · Cited by 4
Self-citationKumar, H. S., Moore, J. M., Steiner, A. C., Sotirakis, E., Schärli, B., Isnard, P., Thiam, K., Wolfer, D. P., & Böttger, E. C. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05031-z · Cited by 3
Pre-therapeutic Microglia Activation and Sex Determine Therapy Effects of Chronic ImmunomodulationPreprint
Biechele, G., Blume, T., Deußing, M., Zott, B., Shi, Y., Xiang, X., Franzmeier, N., Kleinberger, G., Peters, F., Ochs, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.30.445761 · Cited by 3
Purro, S. A., Farmer, M., Quarterman, E., Ravey, J., Thomas, D. X., Noble, E., Turnbull, C., Linehan, J. M., Nazari, T., Brandner, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.11.602448 · Cited by 3
Reevaluating tau reduction as a therapeutic approach for tauopathies: Insights and perspectives
Sun, X., Ogbolu, V. C., Baas, P. W., & Qiang, L. (2023) · Cytoskeleton · doi:10.1002/cm.21790 · Cited by 2
Eed, A., Hamilton, J., Xu, X., Geremia, N. M., Prado, V. F., Prado, M. A. M., Baron, C. A., Menon, R. S., & Brown, A. M. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02183-w · Cited by 2
Smith, V. L., Gidi, B. Z., Bragg, R. M., Cantle, J. P., Ben-Varon, A., Noble, B., Prades, S., Compton, A., Greenfield, J., Korecka, J. A., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102815 · Cited by 2
Kimura, T., Masuda‐Suzukake, M., Hashimoto, M., Sekiyama, K., Kametani, F., Tomita, T., Aoyagi, H., Hisanaga, S., & Hasegawa, M. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02177-8 · Cited by 2
Kano, M., 妙子, 木., Yanagisawa, H., Yamashita, K., Tatsumi, L., Sakai, A., Li, X., Saido, T. C., Saito, T., Takatori, S., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02407-7 · Cited by 2
Self-citationSun, X., Xia, X., Liu, Y., Qi, X., & Xu, T. (2026) · Advanced Sustainable Systems · doi:10.1002/adsu.70442 · Cited by 2
Nicholson, L., Tang, S. J., Karra, T., Abouelatta, H., & Strittmatter, S. M. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00946-0 · Cited by 2
Translating Alzheimer’s disease proteomics into drug discovery opportunities
Drummond, E., Werry, E. L., Kavanagh, T., Genoud, S., Cho, A., Chen, S., Du, J., Hibbs, D. E., & Kassiou, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00035-y · Cited by 2
A Clinically Relevant Mouse Model of Concussion Incorporating High Rotational Forces
Teasell, E. M., Potts, E., Geremia, N. M., Lu, L., Xu, X., Mao, H., & Brown, A. M. (2025) · Neurotrauma Reports · doi:10.1089/neur.2024.0165 · Cited by 2
A novel tauopathy model mimicking molecular and spatial aspects of human tau pathology
Yanai, R., Mitani, T. T., Susaki, E. A., Minamihisamatsu, T., Shimojo, M., Saito, Y., Mizuma, H., Nitta, N., Kaneda, D., Hashizume, Y., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae326 · Cited by 2
Self-citationMorito, T., Watamura, N., Sasaguri, H., Tomita, T., Higuchi, M., Okano, H., Sasaki, E., & Saido, T. C. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251321116 · Cited by 2
Self-citationAguilera, M., Mathis, C., Herbeaux, K., Isik, A., Faranda, D., Battaglia, D. A., & Goutagny, R. (2025) · Imaging Neuroscience · doi:10.1162/imag.a.70 · Cited by 3
Mueller, R. L., Combs, B., & Kanaan, N. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-21920-8 · Cited by 2
Tau Pathology in Neurodegenerative Diseases
Vogels, T., & Hromádka, T. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_4 · Cited by 2
Impaired glucose homeostasis in a tau knock-in mouse model
Benderradji, H., Kraiem, S., Courty, É., Eddarkaoui, S., Bourouh, C., Faivre, É., Rolland, L., Emilie, C., Besegher, M., Oger, F., et al. (2022) · Endocrine Abstracts · doi:10.1530/endoabs.81.p59 · Cited by 2
Generation of C9orf72 h370 mice, an intron 1 humanised C9orf72 repeat-expansion knock-in modelPreprint
Nair, R., Carcolé, M., Thompson, D., Tibbit, C., McLeod, R., Cammack, A. J., Jakubcova, T., Biggs, D., Wyles, M., Parker, M. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.06.636691 · Cited by 2
Preclinical Development of a Vectorized Artificial miRNA Gene Therapy for TauopathiesPreprint
Garza, I. T., Snyder, B., Holmes, S. K., Pearce, K. M., Knight, K. L., & Bailey, R. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.12.681935 · Cited by 2
Distinct mechanistic pathways of early tauopathy revealed by MAPT mutationsPreprint
Foiani, M. S., Nirujogi, R., Watamura, N., Bez, S., Tsefou, E., Santambrogio, A., Patel, S., Hannah, D., Goulbourne, C. N., Fatima, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.14.705716 · Cited by 2
Self-citationGeneration of sophisticated Alzheimer’s disease mouse models and research advances utilizing them
Hashimoto, S., & Saido, T. C. (2023) · Translational and Regulatory Sciences · doi:10.33611/trs.2023-003 · Cited by 1
Self-citationDual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition
Han, J., Jeong, J., Lee, D., Jung, Y., Jin, Y., Jung, E. S., Kim, H. J., Kim, W. Y., Lee, C., & Mook‐Jung, I. (2026) · Advanced Science · doi:10.1002/advs.202513135 · Cited by 1
SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain
Huang, H., Shi, C. H., Yang, W., Piña-Crespo, J. C., Bhatnagar, J., Curatolo, J., Murad, R., Shah, P., Campos, A., Houser, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed6825 · Cited by 1
Decorin is an early CSF biomarker of Alzheimer’s Aβ amyloidosis
Jiang, R., Smailović, U., Haytural, H., Haret, R. M., Shevchenko, G., Tijms, B. M., Gobom, J., Abelein, A., Johansson, J., Zetterberg, H., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.054474 · Cited by 1
A non-human primate model of familial Alzheimer’s disease for translational medicinePreprint
Sato, K., Sasaguri, H., Kumita, W., Kurotani, Y., Inoue, T., Nagata, K., Mihira, N., Sato, K., Sakuma, T., Yamamoto, T., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-265068/v1 · Cited by 1
Self-citationDesai, S., La, J., Balbaa, A., Camporesi, E., Brinkmalm, G., Goyal, K., Alatza, A., Wood, J. I., Tripathi, T., Bez, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.04.621900 · Cited by 1
Self-citationChen, H., Hagar, H. C., Wang, K.-W., Hovde, S., Lin, H., Lin, M.-H., Chang, C.-C., Wang, C.-Y., Chen, C.-Y., Bian, E. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.10.642468 · Cited by 1
Misclassification in memory modification in AppNL-G-F knock-in mouse model of Alzheimer’s diseasePreprint
Huang, M.-L., Suzuki, Y., Sasaguri, H., Saito, T., Saido, T. C., & Imayoshi, I. (2025) · eLife · doi:10.7554/elife.105347.2 · Cited by 1
Self-citationAberrant medial entorhinal cortex dynamics link tau pathology to spatial memory impairmentPreprint
Malone, T. J., Cekada, K., Tyan, J., Chen, L., Wang, G., & Gu, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.30.696887 · Cited by 1
Tsagkogianni, C., Trivisonno, M., Willner, J. S., Garcia-Molinero, C., Tang, Y., Mattina, B., Latorre‐Leal, M., Wang, W., Roussarie, J.-P., & Rodriguez‐Rodriguez, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.15.711617 · Cited by 1
Borcuk, C. (2021) · theses.fr (ABES) · doi:10.70675/c316f2dcz54d3z41cfzb3f5z99c7b2d3cd95 · Cited by 1
Lam, S. (2021) · theses.fr (ABES) · doi:10.70675/60b353ffz56fcz41a2z9e53zf0d9ac078167 · Cited by 1
Ji, Y., Mandal, P., Liu, J., Hu, W., Colon, B. D., Wan, C., Pan, R. W., Guo, D., Zhang, L., Gu, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.06.736894 · Cited by 1
Park, J. H., Kim, B., Al‐Amin, M. M., Tate, M. D., Sharify, A. D., John, S. K., Karahan, H., Lu, H., Dabin, L. C., & Kim, J. (2026) · Alzheimer's & Dementia · doi:10.1002/alz.71742
“73,74 However, APP NL-G-F /MAPT do not develop neurofibrillary tangles and neuronal loss until 24 months, 73 and remain transcriptomically undercharacterized.”
Walker, M. A. (2021) · Scholarship@Western (Western University)
anti NN reactions and meson resonances
Fields, T. H., Jackson, J. D., Roberts, A. M., & Donaldson, R. (1972)
Modified Investigation Tools and Techniques Useful in Alzheimer’s Disease Research
Deore, S. L., Baviskar, B. A., Kide, A. A., Khadabadi, S. S., & Shende, B. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_3
Bansal, V. A., Tan, J. M., Soon, H. R., Zainolabidin, N., Saito, T., & Ch’ng, T. H. (2024) · eLife · doi:10.7554/elife.92069.1
Self-citationSasmita, A. O. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10403
Stoner, A. J., Fu, L., Nicholson, L., Zheng, C., Toyonaga, T., Spurrier, J. M., Laird, W., Cai, Z., & Strittmatter, S. M. (2023) · Figshare · doi:10.6084/m9.figshare.24571848
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226955
Self-citationJiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226976
Self-citationJiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226979
Self-citationJiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226958
Self-citationJiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226970
Self-citationIto, S., Yamauchi, K., Hama, H., Koike, M., Miyawaki, A., & Hioki, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.25.591057
Bansal, V. A., Tan, J. M., Soon, H. R., Zainolabidin, N., Saito, T., & Ch’ng, T. H. (2024) · eLife · doi:10.7554/elife.92069.2
Self-citationTwo major culprits: Amyloidogenic Aβ and non-amyloidogenic tau
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00010-3
Self-citationSaido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00023-1
Self-citationBiomarkers for presymptomatic diagnosis and prognosis
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00001-2
Self-citationApplications of App and MAPT knock-in mice to understanding disease mechanisms
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00006-1
Self-citationHuman genetics: Establishment of cause-and-effect relationships
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00013-9
Self-citationPathological chronology and pathological biochemistry: The beginning of the beginning
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00022-x
Self-citationÁvila-Costa, M. R., Dorado-Martínez, C., Montiel-Flores, E., Ordóñez-Librado, J. L., Gutiérrez-Valdez, A. L., Caballero, C. A. G., Sánchez-Betancourt, J., Erazo, L. R., Tron-Alvarez, R., Rodríguez-Lara, V., et al. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007924
Misclassification in memory modification in AppNL-G-F knock-in mouse model of Alzheimer’s disease
Huang, M.-L., Suzuki, Y., Sasaguri, H., Saito, T., Saido, T. C., & Imayoshi, I. (2025) · eLife · doi:10.1101/2025.01.24.634705
Self-citation
Metadata
- Authors
- Saito, T., Mihira, N., Matsuba, Y., Sasaguri, H., Hashimoto, S., Narasimhan, S., Zhang, B., Murayama, S., Higuchi, M., Lee, V. M. Y., Trojanowski, J. Q., & Saido, T. C.
- Affiliations
- RIKEN Center for Brain Science (JP)
- University of Pennsylvania (US)
- Tokyo Metropolitan Geriatric Hospital (JP)
- National Institutes for Quantum Science and Technology (JP)
- Corresponding author
- Saito, Takashi
- Saido, Takaomi C.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 294
- Issue
- 34
- Pages
- 12754-12765
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC6709628
- OpenAlex
- W2954476098
- Cited by
- 248
- References
- 44
- Citations by year
- 2026: 24 · 2025: 48 · 2024: 52 · 2023: 30 · 2022: 31 · 2021: 34 · 2020: 21 · 2019: 7
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- QST-Repository (National Institutes for Quantum and Radiological Science and Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- MEXT | Japan Society for the Promotion of Science (JSPS) (26290019, JP16H06277)
- JST | Precursory Research for Embryonic Science and Technology (PRESTO) (110650)
- Japan Agency for Medical Research and Development (AMED) (JP18dm027001)
- HHS | National Institutes of Health (NIH) (AG10124, AG 17586)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tauopathy, Alzheimer's disease, amyloid-beta, tau phosphorylation, dystrophic neurites, tau isoforms, amyloid precursor protein
- MeSH terms
- Animals, Disease Models, Animal, Humans, Mice, Inbred C57BL, Mice, Transgenic, tau Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
